Capivasertib (C) plus paclitaxel (P) as first-line treatment of metastatic triple-negative breast cancer (mTNBC): The CAPItello-290 phase III trial Meeting Abstract
| Authors: | Schmid, P.; McArthur, H. L.; CorteĢs, J.; Xu, B.; Cardoso, F.; Casalnuovo, M. L.; Demirci, U.; Freitas, R.; Ghosh, J.; Hegg, R.; Iwata, H.; Chuken, Y. A. L.; Nechaeva, M.; Robson, M. E.; Valencia, R. V.; Lloyd, A.; D'Cruz, C.; Foxley, A.; Park, Y. H. |
| Abstract Title: | Capivasertib (C) plus paclitaxel (P) as first-line treatment of metastatic triple-negative breast cancer (mTNBC): The CAPItello-290 phase III trial |
| Meeting Title: | ESMO Congress 2024 |
| Journal Title: | Annals of Oncology |
| Volume: | 35 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2024 Sept 13-17 |
| Meeting Location: | Barcelona, Spain |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2024-09-01 |
| Start Page: | 1212 |
| End Page: | 1213 |
| Language: | English |
| ACCESSION: | WOS:001326612903026 |
| DOI: | 10.1016/j.annonc.2024.08.2257 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: LBA19 -- Source: Wos |
